Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies
Authors:
- Liying ZhangLZLiying Zhang
- Lianchun LiLLLianchun Li
- Jun LiuJLJun Liu
- Hongling LiHLHongling Li
- Luyong ZhangLZLuyong Zhang
- Limin ChenLCLimin Chen
- Keguang ChengKCKeguang Cheng
- Mingyue ZhengMingyue Zheng
- Xiaoan WenXWXiaoan Wen
- Pu ZhangPZPu Zhang
- Jia HaoJHJia Hao
- 1 June 2011
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (6) , 2011-2021
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (20720102040, 20972174, 30672523, 91029704, 90713037)
- State Key Program of Basic Research of China Grant (2009CB918502)
- National S&T Major Project (2009ZX09501-001)
- Hi-Tech Research and Development Program of China (2006AA020404)
- Shanghai Committee of Science and Technology (10410703900)
- Guangdong Provincial Department of Science and Technology (2010A030100006)
This publication has 26 references indexed in Scilit:
- EDITORIAL [ Inhibition of Glycogenolysis Towards Antidiabetic and Other Therapies (Guest Editor: Laszlo Somsak)]Mini-Reviews in Medicinal Chemistry, 2010
- New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic AgentsCurrent Medicinal Chemistry, 2008
- Naturally Occurring Pentacyclic Triterpenes as Inhibitors of Glycogen Phosphorylase: Synthesis, Structure−Activity Relationships, and X-ray Crystallographic StudiesJournal of Medicinal Chemistry, 2008
- Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerNature Reviews Cancer, 2007
- Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Glycogen Phosphorylase InhibitorsMini-Reviews in Medicinal Chemistry, 2006
- Intervention of Hepatic Glucose Production. Small Molecule Regulators of Potential Targets for Type 2 Diabetes TherapyMini-Reviews in Medicinal Chemistry, 2004
- Glucose Analog Inhibitors of Glycogen Phosphorylases as Potential Antidiabetic Agents: Recent DevelopmentsCurrent Pharmaceutical Design, 2003
- Glycogen Phosphorylase as a Molecular Target for Type 2 Diabetes TherapyCurrent Protein & Peptide Science, 2002
- Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosisNature Medicine, 1995